Antje Güttler

492 total citations
24 papers, 379 citations indexed

About

Antje Güttler is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Antje Güttler has authored 24 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Antje Güttler's work include Cancer, Hypoxia, and Metabolism (7 papers), Enzyme function and inhibition (5 papers) and Natural product bioactivities and synthesis (5 papers). Antje Güttler is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Enzyme function and inhibition (5 papers) and Natural product bioactivities and synthesis (5 papers). Antje Güttler collaborates with scholars based in Germany, South Korea and Pakistan. Antje Güttler's co-authors include Matthias Bache, Dirk Vordermark, Jacqueline Keßler, Henri Wichmann, Matthias Kappler, C. Ostheimer, Swetlana Rot, Helge Täubert, Reinhard Paschke and Matthias Kotzsch and has published in prestigious journals such as International Journal of Molecular Sciences, European Journal of Medicinal Chemistry and Radiotherapy and Oncology.

In The Last Decade

Antje Güttler

23 papers receiving 378 citations

Peers

Countries citing papers authored by Antje Güttler

Since Specialization

Citations

This map shows the geographic impact of Antje Güttler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje Güttler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje Güttler more than expected).

Fields of papers citing papers by Antje Güttler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje Güttler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje Güttler. The network helps show where Antje Güttler may publish in the future.

Co-authorship network of co-authors of Antje Güttler

This figure shows the co-authorship network connecting the top 25 collaborators of Antje Güttler. A scholar is included among the top collaborators of Antje Güttler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje Güttler. Antje Güttler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combination of Betulinic Acid Fragments and Carbonic Anhydrase Inhibitors—A New Drug Targeting Approach 2024 ·Pharmaceutics ·Matthias Bache, (unknown), Andreas Thiel, (unknown), (unknown), (unknown), Antje Güttler, (unknown), Thomas Mueller, Dirk Vordermark, Iris Thondorf, René Csük, Reinhard Paschke	0
2	Zinc Influences the Efficacy of Betulinic Acid Treatment and Radiotherapy in Breast Cancer Cells 2024 ·Antioxidants ·Antje Güttler, (unknown), (unknown), (unknown), Jacqueline Keßler, Ivo Große, Dirk Vordermark, Matthias Bache	1
3	Mitochondria-Targeting 1,5-Diazacyclooctane-Spacered Triterpene Rhodamine Conjugates Exhibit Cytotoxicity at Sub-Nanomolar Concentration against Breast Cancer Cells 2023 ·International Journal of Molecular Sciences ·(unknown), S. WILLIAM BECKER, Thomas Mueller, Matthias Bache, René Csük, Antje Güttler	13
4	Plasma β‐synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy 2023 ·Annals of Clinical and Translational Neurology ·Samir Abu‐Rumeileh, Lorenzo Barba, Matthias Bache, Steffen Halbgebauer, Patrick Oeckl, Petra Steinacker, Antje Güttler, Jacqueline Keßler, (unknown), Christian Strauß, Dirk Vordermark, Markus Otto	6
5	Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients 2023 ·International Journal of Molecular Sciences ·Matthias Bache, (unknown), (unknown), Daniel Medenwald, C. Ostheimer, Antje Güttler, Jacqueline Keßler, Matthias Kappler, Anne Riemann, Oliver Thews, Barbara Seliger, Dirk Vordermark	3
6	SESN2 Knockdown Increases Betulinic Acid-Induced Radiosensitivity of Hypoxic Breast Cancer Cells 2022 ·Cells ·Antje Güttler, Claus Weinholdt, (unknown), (unknown), (unknown), (unknown), (unknown), Jacqueline Keßler, Matthias Kappler, Ivo Große, Dirk Vordermark, Matthias Bache	3
7	MSBA-S – A pentacyclic sulfamate as a new option for radiotherapy of human breast cancer cells 2021 ·European Journal of Medicinal Chemistry ·(unknown), Antje Güttler, (unknown), Immo Serbian, (unknown), (unknown), Jacqueline Keßler, (unknown), Reinhard Paschke, René Csük, Dirk Vordermark, Matthias Bache	11
8	Combined 3-O-acetylbetulin treatment and carbonic anhydrase IX inhibition results in additive effects on human breast cancer cells 2020 ·Chemico-Biological Interactions ·(unknown), Antje Güttler, (unknown), Jacqueline Keßler, (unknown), Reinhard Paschke, Dirk Vordermark, Matthias Bache	18
9	MiR-155-5p and MiR-203a-3p Are Prognostic Factors in Soft Tissue Sarcoma 2020 ·Cancers ·Thomas Greither, Franziska Koser, Hans-Jürgen Holzhausen, Antje Güttler, Peter Würl, Matthias Kappler, Sven Wach, Helge Täubert	9
10	Evaluation of the Betulinic Acid–Cisplatin conjugate APC and its precursor DE9B for the treatment of human malignant glioma 2019 ·Chemico-Biological Interactions ·Matthias Bache, (unknown), (unknown), Antje Güttler, Jacqueline Keßler, Henri Wichmann, Matthias Kappler, (unknown), Reinhard Paschke, Dirk Vordermark	6
11	Radiosensitization and a Less Aggressive Phenotype of Human Malignant Glioma Cells Expressing Isocitrate Dehydrogenase 1 (IDH1) Mutant Protein: Dissecting the Mechanisms 2019 ·Cancers ·Jacqueline Keßler, Tim Hohmann, Antje Güttler, (unknown), C. Ostheimer, (unknown), Matthias Bache, Faramarz Dehghani, Dirk Vordermark	18
12	P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients 2017 ·Clinical and Translational Radiation Oncology ·Matthias Kappler, Johanna Kotrba, (unknown), Matthias Bache, Swetlana Rot, Daniel Bethmann, Henri Wichmann, Antje Güttler, Udo Bilkenroth, (unknown), (unknown), Jacqueline Keßler, Thomas Greither, Helge Täubert, Alexander W. Eckert, Dirk Vordermark	26
13	mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma 2015 ·Oncology Reports ·Matthias Bache, Swetlana Rot, Jacqueline Keßler, Antje Güttler, Henri Wichmann, Thomas Greither, Sven Wach, Helge Täubert, Ariane Söling, Udo Bilkenroth, Matthias Kappler, Dirk Vordermark	28
14	Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines 2015 ·Radiation Oncology ·Gisela Wohlleben, Agmal Scherzad, Antje Güttler, Dirk Vordermark, (unknown), Michael Flentje, Bülent Polat	14
15	IDH1R132H mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status 2015 ·Radiotherapy and Oncology ·Jacqueline Keßler, Antje Güttler, Henri Wichmann, Swetlana Rot, Matthias Kappler, Matthias Bache, Dirk Vordermark	34
16	Targeting of EGFR and HER2 with therapeutic antibodies and siRNA 2014 ·Strahlentherapie und Onkologie ·Henri Wichmann, Antje Güttler, Matthias Bache, Helge Täubert, Swetlana Rot, Jacqueline Keßler, Alexander W. Eckert, Matthias Kappler, Dirk Vordermark	21
17	Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients 2014 ·Strahlentherapie und Onkologie ·Henri Wichmann, Antje Güttler, Matthias Bache, Helge Täubert, Martina Vetter, Peter Würl, (unknown), Alexander W. Eckert, Matthias Kappler, Dirk Vordermark	7
18	Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer 2014 ·BMC Cancer ·C. Ostheimer, Matthias Bache, Antje Güttler, Thomas S. Reese, Dirk Vordermark	21
19	A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer 2013 ·Strahlentherapie und Onkologie ·C. Ostheimer, Matthias Bache, Antje Güttler, Matthias Kotzsch, Dirk Vordermark	36
20	Osteopontin and splice variant expression level in human malignant glioma: Radiobiologic effects and prognosis after radiotherapy 2013 ·Radiotherapy and Oncology ·Antje Güttler, (unknown), (unknown), Henri Wichmann, Jacqueline Keßler, C. Ostheimer, Ariane Söling, Christian Strauß, (unknown), Matthias Kappler, Dirk Vordermark, Matthias Bache	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact